DarioHealth Corp. Files 8-K
Ticker: DRIO · Form: 8-K · Filed: Sep 12, 2025 · CIK: 1533998
| Field | Detail |
|---|---|
| Company | Dariohealth CORP. (DRIO) |
| Form Type | 8-K |
| Filed Date | Sep 12, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $1.00 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, other-events
TL;DR
DarioHealth filed an 8-K for 'Other Events' on 9/12/25 - details TBD.
AI Summary
DarioHealth Corp. filed an 8-K on September 12, 2025, reporting "Other Events." The filing does not contain specific details about the nature of these events, dollar amounts, or definitive dates beyond the filing date itself. The company, formerly known as LabStyle Innovations Corp., is incorporated in Delaware and headquartered in New York.
Why It Matters
This filing indicates a material event has occurred for DarioHealth Corp., requiring disclosure to investors. However, the lack of specific details in this report necessitates further investigation to understand the implications.
Risk Assessment
Risk Level: medium — The filing is an 8-K for 'Other Events' without specific details, creating uncertainty about the nature and impact of the reported event.
Key Players & Entities
- DarioHealth Corp. (company) — Registrant
- LabStyle Innovations Corp. (company) — Former company name
- September 12, 2025 (date) — Filing date and earliest event reported
FAQ
What specific 'Other Events' are being reported by DarioHealth Corp. in this 8-K filing?
The provided filing excerpt does not specify the nature of the 'Other Events' beyond the general categorization.
What is the significance of the filing date and the date of the earliest event reported?
Both the filing date and the date of the earliest event reported are September 12, 2025, indicating the events occurred on or before this date.
What was DarioHealth Corp.'s former company name?
DarioHealth Corp.'s former company name was LabStyle Innovations Corp.
In which state is DarioHealth Corp. incorporated?
DarioHealth Corp. is incorporated in Delaware.
What is the principal executive office address for DarioHealth Corp.?
The principal executive office address for DarioHealth Corp. is 322 W. 57th St, #33B, New York, New York 10019.
Filing Stats: 478 words · 2 min read · ~2 pages · Grade level 12.3 · Accepted 2025-09-12 17:24:17
Key Financial Figures
- $0.0001 — registered Common Stock, par value $0.0001 per share DRIO The Nasdaq Capital M
- $1.00 — the Company's common stock had been at $1.00 per share or greater and that according
Filing Documents
- tm2526037d1_8k.htm (8-K) — 23KB
- 0001104659-25-089629.txt ( ) — 184KB
- drio-20250912.xsd (EX-101.SCH) — 3KB
- drio-20250912_lab.xml (EX-101.LAB) — 33KB
- drio-20250912_pre.xml (EX-101.PRE) — 22KB
- tm2526037d1_8k_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. As previously disclosed, on September 16, 2024, DarioHealth Corp. (the "Company") received a letter from the listing qualifications staff (the "Staff") of the Nasdaq Stock Market ("Nasdaq") notifying the Company that it was not in compliance with the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing. On September 12, 2025, the Company received a letter from the Staff notifying the Company that the Staff has determined that for the last 10 consecutive business days, from August 28, 2025 to September 11, 2025 , the closing bid price of the Company's common stock had been at $1.00 per share or greater and that accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2) and the matter is now closed.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: September 12, 2025 DARIOHEALTH CORP. By: /s/ Chen Franco-Yehuda Name: Chen Franco-Yehuda Title: Chief Financial Officer, Treasurer and Secretary